Publications by authors named "Frederic Cosledan"

Claim this Profile
C
Copper chelator induced efficient episodic memory recovery in a non-transgenic Alzheimer's mouse model.
Johnatan Ceccom, Frédéric Coslédan, Hélène Halley, Bernard Francès, Jean Michel Lassalle

PLoS One· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antischistosomal activity of trioxaquines: in vivo efficacy and mechanism of action on Schistosoma mansoni.
Julien Portela, Jérôme Boissier, Benjamin Gourbal, Vincent Pradines, Vincent Collière

PLoS Negl Trop Dis· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary investigations of the effect of lipophilic analogues of the active metabolite of isoniazid toward bacterial and plasmodial strains.
Tamara Delaine, Vania Bernardes-Génisson, Annaïk Quémard, Patricia Constant, Frédéric Cosledan

Chem Biol Drug Des· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trioxaquine PA1259 alkylates heme in the blood-feeding parasite Schistosoma mansoni.
Vincent Pradines, Julien Portela, Jérôme Boissier, Frédéric Coslédan, Bernard Meunier

Antimicrob Agents Chemother· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trioxaferroquines as new hybrid antimalarial drugs.
François Bellot, Frédéric Coslédan, Laure Vendier, Jacques Brocard, Bernard Meunier

J Med Chem· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activities of trioxaquines against Schistosoma mansoni.
Jérôme Boissier, Frédéric Coslédan, Anne Robert, Bernard Meunier

Antimicrob Agents Chemother· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docking studies of structurally diverse antimalarial drugs targeting PfATP6: no correlation between in silico binding affinity and in vitro antimalarial activity.
Fatima Bousejra-El Garah, Jean-Luc Stigliani, Frédéric Coslédan, Bernard Meunier, Anne Robert

ChemMedChem· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of a trioxaquine as an antimalarial drug candidate.
Frédéric Coslédan, Laurent Fraisse, Alain Pellet, François Guillou, Benjamin Mordmüller

Proc Natl Acad Sci U S A· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis